1Muller AJ,Prendergast GC.Indoleamine 2,3-dioxygenase in immune suppression and cancer.Curr Cancer Drug Targets,2007,7:31-40.
2Inaba T,Ino K,Kajiyama H,et al.Indoleamine 2,3-dioxygenase expression predicts impaired survival of invasive cervical cancer patients treated with radical hysterectomy.Gynecol Oncol,2010,117:423-428.
3Pan K,Wang H,Chen MS,et al.Expression and prognosis role of indoleamine 2,3-dioxygenase in hepatocellular carcinoma.J Cancer Res Clin Oncol,2008,134:1247-1253.
4Wicki A,Lehembre F,Wick N,et al.Tumor invasion in the absence of epithelial-mesenchymal transition:podoplanin-mediated remodeling of the actin cytoskeleton.Cancer Cell,2006,9:261-272.
5Barth MC,Ahluwalia N,Anderson TJ,et al.Kynurenic acid triggers firm arrest of leukocytes to vascular endothelium under flow conditions.J Biol Chem,2009,284:19189-19195.
6Blanc JF.Bisson C,Frankenne F,et al.Hepatocarcinoma cell lines down-regulate matrix metalloproteinase-2 expression in human hepatic myofibroblasts.Int J Oncol,2002,20:1129-1136.
